News & Events
By combining TRIUMF’s expertise in manufacturing isotopes and radiolabelling conjugates with CDRD’s ability to identify and validate potential biological targets to...
Read the articleCDRD is a proud sponsor of the Healthkick Invest at part of Health Innovation Week hosted by MaRS Discovery District from...
Read the articleThe Renaissance of Radio Pharmaceuticals – A Commercial Perspective
CDRD is a proud sponsor of the TAT11 International Symposium on targeted alpha therapy hosted by Canadian Nuclear Laboratories. We are...
Read the articleCDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial
This new investment will enable Sitka and its partner Cancer Research UK (CRUK) to accelerate critical development activities and rapidly enter...
Read the articleCDRD Appoints Wendy Hurlburt & William Charnetski to its Board of Directors
Vancouver, Canada: CDRD, Canada’s national life sciences venture, is pleased to announce the appointments of Ms. Wendy Hurlburt and Mr. William...
Read the articleCDRD Recognized as Top Employer for Science Students
CDRD has been selected for a Science Co-op Employer Recognition Award by the University of British Columbia (UBC). In addition, two...
Read the articleZucara Therapeutics – Helping people with diabetes sleep safely and soundly
On World Diabetes Day, Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is raising awareness about hypoglycemia (low blood sugar)...
Read the articleTo exemplify the collaborative spirit and leadership needed to advance the Canadian health and biosciences sector, Canadian life sciences leaders –...
Read the articleThrough this new structure, CDRD will be even stronger, and seek to realize our vision of Canadian life sciences leading the...
Read the articleCDRD Appoints Didier Leconte to its Board of Directors
Didier is at the forefront of life sciences investment in Canada, working with the Fonds de solidarité FTQ on a mission...
Read the article